Master of Health Science (MHS) in Health Economics and Outcomes Research
Offered By: Department of Health Policy and Management
Onsite / Full-Time (9 months), Online / Full-Time (9 months), Online / Part-Time (2 years)
About This Program
The MHS-HEOR is a nine-month program focused in economic evaluation and outcomes research methods for healthcare. This rigorous program develops data analytic and economic modeling skills, as employed in the health policy context. In addition to coursework, students complete an independent capstone project with guidance from faculty using taught methods.
Students enrolled in this program have the opportunity to take courses from several departments and from faculty with expertise in a variety of discipline-many of which are true leaders in the respective fields. Through their coursework, experience at seminars, and capstone projects, provides a multidisciplinary experience.
Health economics and outcomes research is an applied field of study drawing upon two disciplines: economic evaluation and outcomes research. Methods in this field are used to promote the efficient and equitable allocation of healthcare resources in public health.
The discipline of economic evaluation is grounded on seminal theories of health economics that relate the value of healthcare to individuals and society. Statistical and decision sciences further enable researchers to build upon these theories and model the value of healthcare technologies to individuals and society. Some examples of this research include the evaluation of the value of new pharmaceuticals to existing therapies, the value of vaccines to society, or the value of a public health campaign to provide safety.
The discipline of outcomes research is grounded on seminal theories of health services that relate the role of healthcare to improving the lives of individuals and society. These theories enable researchers to identify important clinical, patient, provider outcomes; design measurement techniques to capture different outcomes; and incorporate outcomes measurement into health systems. Specific examples of this research include assessing the impact of new pharmaceuticals on patient outcomes, how to measure a new approach to healthcare delivery, or how to validate a new patient reported outcomes instrument for a pediatric population.
What Can You Do With This Degree?
Graduates of this program are well positioned to pursue careers in academia, government, and industry. This program also prepares students for further doctoral training in economics and health policy.
- Health Economist
- Healthcare Analyst
- Senior Consultant
- Data Analyst
- Research Associate
- Research Fellow
For general admissions requirements, please visit the How to Apply page. This specific program also requires:
An undergraduate-level calculus course
Standardized Test Scores
Standardized test scores are not required and not reviewed for this program. If you have taken a standardized test such as the GRE, GMAT, or MCAT and want to submit your scores, please note that they will not be used as a metric during the application review. Applications will be reviewed holistically based on all required application components.
Jeromie Ballreich, PhD '17, MHS '12, Program Director
is a health economist who focuses on leading research in areas of pharmaceutical policy and economic evaluations.
Tuition and Funding
The Department of Health Policy and Management does not offer any scholarships or tuition support for students of this program. If you are interested in learning what financial aid opportunities are available on a schoolwide level, please look to the Office of Financial Aid.
- Check out similar programs at the Bloomberg School to find the best fit.
- Master of Health Science (MHS) in Global Health Economics, focusing on health economics in low and middle-income countries